NCT02191826View on ClinicalTrials.gov

Study of SOM0226 in Familial Amyloid Polyneuropathy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Familial Amyloid Polyneuropathy (FAP)
Interventions
DRUG

SOM0226

Oral

Trial Locations (1)

08035

Hospital Vall d'Hebron, Barcelona

All Listed Sponsors
collaborator

Hospital Vall d'Hebron

OTHER

lead

SOM Innovation Biotech SA

INDUSTRY

NCT02191826 - Study of SOM0226 in Familial Amyloid Polyneuropathy | Biotech Hunter | Biotech Hunter